The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension

Currently available noninvasive markers for assessing disease severity and mortality risk in pulmonary arterial hypertension (PAH) are unrelated to fundamental disease biology. Endostatin, an angiostatic peptide known to inhibit pulmonary artery endothelial cell migration, proliferation and survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Catherine E., Griffiths, Megan, Yang, Jun, Nies, Melanie K., Vaidya, R. Dhananjay, Brandal, Stephanie, Martin, Lisa J., Pauciulo, Michael W., Lutz, Katie A., Coleman, Anna W., Austin, Eric D., Ivy, D. Dunbar, Nichols, William C., Everett, Allen D., Hassoun, Paul M., Damico, Rachel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503279/
https://www.ncbi.nlm.nih.gov/pubmed/34651041
http://dx.doi.org/10.1183/23120541.00378-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503279/
https://www.ncbi.nlm.nih.gov/pubmed/34651041
http://dx.doi.org/10.1183/23120541.00378-2021

Ejemplares similares